Not applicableUnknownNCT04837950What this trial is testingChanges in Pleural Cavity Volume and Surgical ExposureWho this might be right forThoracic Cancer Odense University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03623750What this trial is testingE GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL CWho this might be right forCarcinoma, Non-Small-Cell Lung Instituto Oncológico Dr Rosell 23
Early research (Phase 1)Study completedNCT02215850What this trial is testingSafety Study of SLC-0111 in Subjects With Advanced Solid TumoursWho this might be right forSolid Tumours Welichem Biotech Inc. 24
Not applicableWithdrawnNCT01434550What this trial is testingPhase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWho this might be right forPancreatic Tumor H. Lee Moffitt Cancer Center and Research Institute
Not applicableStudy completedNCT01631318What this trial is testingPilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver MetastasesWho this might be right forLiver MetastasesColon Cancer Stanford University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06161818What this trial is testingTotal Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric JunctionWho this might be right forEsophageal CancerAdenocarcinoma of the Esophagus Erasmus Medical Center 216
Testing effectiveness (Phase 2)Study completedNCT00206518What this trial is testingTaxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer PatientsWho this might be right forBreast Cancer Mothaffar Rimawi 167
Testing effectiveness (Phase 2)Study completedNCT00014690What this trial is testingZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer AstraZeneca
Testing effectiveness (Phase 2)Looking for participantsNCT04724018What this trial is testingSacituzumab Govitecan Plus EV in Metastatic UCWho this might be right forUrothelial CancerMetastatic Urothelial CarcinomaMetastatic Urothelial Carcinoma of the Renal Pelvis and Ureter+1 more Dana-Farber Cancer Institute 106
Early research (Phase 1)Study completedNCT00003890What this trial is testingMG98 in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 19
Not applicableStudy completedNCT00903890What this trial is testingCardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's LymphomaWho this might be right forHodgkin DiseaseLymphoma, Non-Hodgkin University of Rochester 32
Not applicableLooking for participantsNCT05831397What this trial is testingExtracellular Vesicles in Breast Cancer Patientsin Undergone Neoadjuvant ChemotherapyWho this might be right forBreast Cancer Istituti Clinici Scientifici Maugeri SpA 35
Not applicableLooking for participantsNCT01247597What this trial is testingDICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History StudyWho this might be right forPleuropulmonary BlastomaCystic NephromaOvarian Sertoli-Leydig Cell Tumors+2 more National Cancer Institute (NCI) 1,500
Testing effectiveness (Phase 2)Ended earlyNCT05355597What this trial is testing"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"Who this might be right forMusculoskeletal DiseasesSoft Tissue Mass Atlantic Health System 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT04127110What this trial is testingActivity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC PatientsWho this might be right forNon Small Cell Lung Cancer European Organisation for Research and Treatment of Cancer - EORTC 68
Testing effectiveness (Phase 2)UnknownNCT04082910What this trial is testingMetoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T CellsWho this might be right forSolid TumorHematological Malignancy Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00845910What this trial is testingCirculating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 22
Not applicableStudy completedNCT05932810What this trial is testingEvaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With CancerWho this might be right forDepressionDepressive SymptomsCancer Medical University of South Carolina 30
Testing effectiveness (Phase 2)WithdrawnNCT04495010What this trial is testingNeoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma ParticipantsWho this might be right forMelanoma Bristol-Myers Squibb
Large-scale testing (Phase 3)Looking for participantsNCT05726110What this trial is testingSelinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed or Refractory Acute Myeloid Leukemia Shanxi Bethune Hospital 50